The methionine cycle sustains the mesenchymal phenotype of tumor cells and drives PDA progression
Mesenchymal traits are associated with poor prognosis in Pancreatic Ductal Adenocarcinoma (PDA), but direct targeting of mesenchymal tumor cells remains a